Targeting Antigens to Dendritic Cell Receptors for Vaccine Development

  • Apostolopoulos V
  • Thalhammer T
  • Tzakos A
  • et al.
Citations of this article
Mendeley users who have this article in their library.


Dendritic cells (DCs) are highly specialized antigen presenting cells of the immune system which play a key role in regulating immune responses. Depending on the method of antigen delivery, DCs stimulate immune responses or induce tolerance. As a consequence of the dual function of DCs, DCs are studied in the context of immunotherapy for both cancer and autoimmune diseases. In vaccine development, a major aim is to induce strong, specific T-cell responses. This is achieved by targeting antigen to cell surface molecules on DCs that efficiently channel the antigen into endocytic compartments for loading onto MHC molecules and stimulation of T-cell responses. The most attractive cell surface receptors, expressed on DCs used as targets for antigen delivery for cancer and other diseases, are discussed.




Apostolopoulos, V., Thalhammer, T., Tzakos, A. G., & Stojanovska, L. (2013). Targeting Antigens to Dendritic Cell Receptors for Vaccine Development. Journal of Drug Delivery, 2013, 1–22.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free